ALK Antibody (4A4), mAb, Mouse

ALK (4A4), mAb, Mouse

Anaplastic lymphoma kinase (ALK) known as ALK tyrosine kinase receptor or CD246, is a tyrosine kinase receptor. ALK is an important biomarker for diagnosis of non-small cell lung cancer (NSCLC). Zykadia (Ceritinib) has been permitted for treating patent with ALK-Positive NSCLC.
V02101
¥65,941.00

Ask us a question
Description

Anaplastic lymphoma kinase (ALK) known as ALK tyrosine kinase receptor or CD246, is a tyrosine kinase receptor. ALK is an important biomarker for diagnosis of non-small cell lung cancer (NSCLC). Zykadia (Ceritinib) has been permitted for treating patent with ALK-Positive NSCLC.
Synonyms

ALK Antibody (4A4), mAb, Mouse

Note

GenScript can customize this product per customer's request including product size, buffer components, etc.

Properties
Storage For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.

Background
Target Background Anaplastic lymphoma kinase (ALK) known as ALK tyrosine kinase receptor or CD246, is a tyrosine kinase receptor. ALK is an important biomarker for diagnosis of non-small cell lung cancer (NSCLC). Zykadia (Ceritinib) has been permitted for treating patent with ALK-Positive NSCLC.